Clinical Trial Update: Plasma Levels of MK0633 in Children Ages 6-12 (0633-023) [Phase 1]

View source ↗

Summary

This completed Phase 1 trial reports the plasma PK levels of MK0633 in children aged 6-12 with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK0633

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED